Verastem Oncology Reports Third Quarter 2019 Financial Results and Recent Company Progress

Go back to Verastem Oncology Reports Third Quarter 2019 Financial Results and Recent Company Progress
VERASTEM SHS (NASDAQ: VSTM) Delayed: 4.12 --0 (-0%)
Previous Close $4.12    52 Week High $2.43 
Open $4.12    52 Week Low $1.05 
Day High $4.12    P/E N/A 
Day Low $4.12    EPS $-1.79 
Volume 5,496